drugset

drugset / Trial / NCT00219635

Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation

NCT00219635 ↗

Phase 2/3 Completed 138 enrolled Pfizer

RandomizedParallel-groupDouble-blindTreatment

Summary

Assessment of efficacy and safety UK-390,957

Timeline

Start: 2005-01
Primary completion: 2005-07
Completion: 2005-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	UK-390,957	Small molecule	—	—

Indications